BioSpace News Archive

Plus, Sex-Based Approaches May Improve Diagnostic Accuracy in Alzheimer’s

Second Genome today announced the appointment of Anupama S. Hoey as chief business officer. In her role, Ms. Hoey will be leading all corporate development activities and strategic alliance opportunities for the company.

Interlink Electronics, Inc. announced that it has recently received purchase orders of $880,000 from an existing prestigious medical customer. This order is for deliveries from October 2018 to June 2019.

Gossamer Bio Inc. (“Gossamer Bio”), today announced the closing of a $230 million Series B.

PharmaCyte Biotech today announced that it has successfully completed a study on the stability after “hand thawing” syringes of the Cell-in-a-Box® encapsulated cells that will be used, in combination with low doses of the cancer prodrug ifosfamide, for the treatment of locally advanced, non-metastatic, inoperable pancreatic cancer.

Synexus HealthyMinds Registry will support some of the largest studies ever undertaken to identify ways to prevent Alzheimer’s disease and other forms of dementia

Azafaros, today announced the closing of a seed financing round. BioGeneration Ventures (BGV) is the founding investor.

Thomas Fairfull, President and Chief Executive Officer of FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE) (OTC:FSDDF), is pleased to announce the appointment of a Special Committee of the Board of Directors to focus on Merger and Acquisition Opportunities and also the appointment of Donal Carroll as interim Chief Financial Officer.

VSAT Evaluates vascular function, determines cardiovascular risks, provides prognosis of vascular diseases, objectively quantifies whether a current intervention plan is working synergistically with each patient’s unique physiology, and includes added benefits of stress and pain assessment.

French health and beauty care company updates IP management system to improve efficiency